|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09906 HONLIV HEALTH
Nominal 
2.100 +0.020 (+0.962%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 91,559 | 118,472 | 91,444 | 74,614 |
| Net Cash from / (used in) Investing Activities | -- | (88,762) | (19,161) | (50,461) | (80,062) |
| Net Cash from / (used in) Financing Activities | -- | (19,116) | (117,848) | (76,872) | 215,156 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (16,319) | (18,537) | (35,889) | 209,708 |
| Cash & Cash Equivalents at beginning of period | -- | 255,238 | 263,610 | 302,478 | 104,602 |
| Effect of Foreign Exchange Rate Changes | -- | 836 | 10,165 | (2,979) | (11,832) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 239,755 | 255,238 | 263,610 | 302,478 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 20,042,000 |
| %Change | -17.397% |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.936 |